Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

MediWound (MDWD) Other Non Operating Income (2016 - 2025)

Historic Other Non Operating Income for MediWound (MDWD) over the last 10 years, with Q3 2025 value amounting to -$13000.0.

  • MediWound's Other Non Operating Income fell 22500.0% to -$13000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$61000.0, marking a year-over-year increase of 7749.08%. This contributed to the annual value of $47000.0 for FY2024, which is 7513.23% down from last year.
  • Latest data reveals that MediWound reported Other Non Operating Income of -$13000.0 as of Q3 2025, which was down 22500.0% from -$6000.0 recorded in Q2 2025.
  • MediWound's Other Non Operating Income's 5-year high stood at $283000.0 during Q2 2022, with a 5-year trough of -$482000.0 in Q2 2021.
  • For the 5-year period, MediWound's Other Non Operating Income averaged around $7294.1, with its median value being -$4000.0 (2024).
  • The largest annual percentage gain for MediWound's Other Non Operating Income in the last 5 years was 22405.06% (2021), contrasted with its biggest fall of 84509.8% (2021).
  • Over the past 5 years, MediWound's Other Non Operating Income (Quarter) stood at $101000.0 in 2021, then plummeted by 40.59% to $60000.0 in 2022, then tumbled by 675.0% to -$345000.0 in 2023, then surged by 92.17% to -$27000.0 in 2024, then soared by 51.85% to -$13000.0 in 2025.
  • Its Other Non Operating Income stands at -$13000.0 for Q3 2025, versus -$6000.0 for Q2 2025 and -$15000.0 for Q1 2025.